Egypt
· Delayed Price · Currency is EGP MPCI Statistics
Total Valuation
Memphis Pharmaceuticals & Chemical Industries has a market cap or net worth of EGP 324.06 million. The enterprise value is -144.62 million.
| Market Cap | 324.06M |
| Enterprise Value | -144.62M |
Important Dates
The last earnings date was Thursday, November 14, 2024.
| Earnings Date | Nov 14, 2024 |
| Ex-Dividend Date | n/a |
Share Statistics
Memphis Pharmaceuticals & Chemical Industries has 5.63 million shares outstanding.
| Current Share Class | n/a |
| Shares Outstanding | 5.63M |
| Shares Change (YoY) | n/a |
| Shares Change (QoQ) | n/a |
| Owned by Insiders (%) | 0.00% |
| Owned by Institutions (%) | n/a |
| Float | 1.77M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| PB Ratio | n/a |
| P/TBV Ratio | n/a |
| P/FCF Ratio | 11.18 |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | -0.47 |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | -4.99 |
Financial Position
The company has a current ratio of 1.31, with a Debt / Equity ratio of 0.50.
| Current Ratio | 1.31 |
| Quick Ratio | 1.10 |
| Debt / Equity | 0.50 |
| Debt / EBITDA | 0.44 |
| Debt / FCF | 4.94 |
| Interest Coverage | 21.68 |
Financial Efficiency
Return on equity (ROE) is 147.62% and return on invested capital (ROIC) is 68.72%.
| Return on Equity (ROE) | 147.62% |
| Return on Assets (ROA) | 18.17% |
| Return on Capital (ROIC) | 68.72% |
| Revenue Per Employee | 7.56M |
| Profits Per Employee | 2.14M |
| Employee Count | 144 |
| Asset Turnover | 1.02 |
| Inventory Turnover | 3.59 |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -2.44% in the last 52 weeks.
| Beta (5Y) | n/a |
| 52-Week Price Change | -2.44% |
| 50-Day Moving Average | 49.85 |
| 200-Day Moving Average | 74.48 |
| Relative Strength Index (RSI) | 52.29 |
| Average Volume (20 Days) | 72,253 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Memphis Pharmaceuticals & Chemical Industries had revenue of EGP 1.09 billion and earned 307.55 million in profits.
| Revenue | 1.09B |
| Gross Profit | 432.62M |
| Operating Income | 309.12M |
| Pretax Income | 378.95M |
| Net Income | 307.55M |
| EBITDA | 322.38M |
| EBIT | 309.12M |
| Earnings Per Share (EPS) | n/a |
Balance Sheet
The company has 611.96 million in cash and 143.29 million in debt, giving a net cash position of 468.67 million or 83.32 per share.
| Cash & Cash Equivalents | 611.96M |
| Total Debt | 143.29M |
| Net Cash | 468.67M |
| Net Cash Per Share | 83.32 |
| Equity (Book Value) | 288.51M |
| Book Value Per Share | n/a |
| Working Capital | 292.79M |
Cash Flow
In the last 12 months, operating cash flow was 55.72 million and capital expenditures -26.73 million, giving a free cash flow of 28.99 million.
| Operating Cash Flow | 55.72M |
| Capital Expenditures | -26.73M |
| Free Cash Flow | 28.99M |
| FCF Per Share | 5.15 |
Margins
Gross margin is 39.73%, with operating and profit margins of 28.39% and 28.24%.
| Gross Margin | 39.73% |
| Operating Margin | 28.39% |
| Pretax Margin | 34.80% |
| Profit Margin | 28.24% |
| EBITDA Margin | 29.61% |
| EBIT Margin | 28.39% |
| FCF Margin | 2.66% |
Dividends & Yields
This stock pays an annual dividend of 4.00, which amounts to a dividend yield of 6.94%.
| Dividend Per Share | 4.00 |
| Dividend Yield | 6.94% |
| Dividend Growth (YoY) | 100.00% |
| Years of Dividend Growth | 2 |
| Payout Ratio | 3.96% |
| Buyback Yield | n/a |
| Shareholder Yield | 6.94% |
| Earnings Yield | n/a |
| FCF Yield | 8.95% |
Stock Splits
The last stock split was on May 14, 2009. It was a forward split with a ratio of 1.5.
| Last Split Date | May 14, 2009 |
| Split Type | Forward |
| Split Ratio | 1.5 |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | n/a |